# AmbioPharm, Inc, Beech Island, SC – FDA Inspections

Source: https://www.keypedia.com/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf

> Inspection records and compliance data for AmbioPharm, Inc in Beech Island, South Carolina. 6 FDA inspections on record, 2 Form 483s, last inspected February 09, 2023.

---

## Details

- Name: AmbioPharm, Inc
- FEI Number: 3006446551
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: 1024 Dittman Ct
- City: Beech Island
- State: South Carolina
- Zip Code: 29842
- Country Name: United States
- Address: 1024 Dittman Ct, Beech Island, South Carolina 29842, United States
- Country: United States

## Related Documents

- [483 - AmbioPharm, Inc - 2023-02-09](https://www.keypedia.com/records/483/ambiopharm-inc/f5b141ab-3baf-4e5b-9481-6e991f46418e) — source: FDA, date: February 9, 2023
- [FDA Inspection 1196909 - AmbioPharm, Inc - 2023-02-09](https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/1876e58a-256b-4566-b2d8-992e46cd34e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 9, 2023
- [EIR - AmbioPharm, Inc - 2017-07-05](https://www.keypedia.com/records/eir/ambiopharm-inc/d2d8aee7-6808-4db8-8048-ffcf28e9bb05) — source: FDA, date: July 5, 2017
- [FDA Inspection 1018621 - AmbioPharm, Inc - 2017-07-05](https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/034acc5a-11fe-467b-89ef-f72b1cbff8e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 5, 2017
- [FDA Inspection 900896 - AmbioPharm, Inc - 2014-10-09](https://www.keypedia.com/records/fda_inspections/ambiopharm-inc/2c31fbf0-16c7-41b7-b568-fb6648633d40) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 9, 2014
- FDA Inspection 826320 - AmbioPharm, Inc - 2013-03-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2013
- FDA Inspection 740844 - AmbioPharm, Inc - 2011-08-16 — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2011
- FDA Inspection 546751 - AmbioPharm, Inc - 2008-11-04 — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2008

## Related Companies

- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [AMPAC Fine Chemicals Texas LLC](https://www.keypedia.com/companies/ampac-fine-chemicals-texas-llc/ac762726-377c-4dbc-bd0b-6eb3be30151b)
- [Sun Pharmaceutical Industries Ltd](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/771469b2-c59c-423e-9ae7-6ce113d3928a)
- [Pfizer Asia Manufacturing Pte Ltd.](https://www.keypedia.com/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [Yuhan Chemical Inc.](https://www.keypedia.com/companies/yuhan-chemical-inc/e849010a-40f7-445b-9bc8-de7e15900a80)
- [Meiji Seika Pharma Co., Ltd.](https://www.keypedia.com/companies/meiji-seika-pharma-co-ltd/9f210099-6346-4340-9f86-521eb46b2629)
- [Lonza Biologics Porrino SL](https://www.keypedia.com/companies/lonza-biologics-porrino-sl/d45fc8fa-ae67-4a12-8cc5-193f3d428984)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/f96f4f92-5b20-4b5d-91d8-5b0dbe430494)
- [Divi's Laboratories Ltd. (Unit II)](https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf)
- [Auro Peptides Limited](https://www.keypedia.com/companies/auro-peptides-limited/4b0dd862-e510-4737-9a98-522e70a98627)

## Related Officers

- [company_representative](https://www.keypedia.com/people/chris-bain/35f4b0d7-ea14-49cc-97dd-b02b09771dcb)
- [investigator](https://www.keypedia.com/people/darryl-t-newell/7767123d-7743-4365-bc9b-30fdd6aaf802)
- [Lilia M Lugo](https://www.keypedia.com/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)
